1. Home
  2. HERZ vs SCLX Comparison

HERZ vs SCLX Comparison

Compare HERZ & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HERZ
  • SCLX
  • Stock Information
  • Founded
  • HERZ N/A
  • SCLX 2011
  • Country
  • HERZ United States
  • SCLX United States
  • Employees
  • HERZ N/A
  • SCLX N/A
  • Industry
  • HERZ Investment Managers
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HERZ Finance
  • SCLX Health Care
  • Exchange
  • HERZ Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • HERZ 38.2M
  • SCLX 35.7M
  • IPO Year
  • HERZ N/A
  • SCLX N/A
  • Fundamental
  • Price
  • HERZ $2.42
  • SCLX $15.72
  • Analyst Decision
  • HERZ
  • SCLX Strong Buy
  • Analyst Count
  • HERZ 0
  • SCLX 3
  • Target Price
  • HERZ N/A
  • SCLX $367.50
  • AVG Volume (30 Days)
  • HERZ N/A
  • SCLX 264.5K
  • Earning Date
  • HERZ N/A
  • SCLX 08-19-2025
  • Dividend Yield
  • HERZ N/A
  • SCLX N/A
  • EPS Growth
  • HERZ N/A
  • SCLX N/A
  • EPS
  • HERZ N/A
  • SCLX N/A
  • Revenue
  • HERZ N/A
  • SCLX $50,710,000.00
  • Revenue This Year
  • HERZ N/A
  • SCLX $89.26
  • Revenue Next Year
  • HERZ N/A
  • SCLX $203.95
  • P/E Ratio
  • HERZ N/A
  • SCLX N/A
  • Revenue Growth
  • HERZ N/A
  • SCLX 7.79
  • 52 Week Low
  • HERZ N/A
  • SCLX $3.60
  • 52 Week High
  • HERZ N/A
  • SCLX $49.00
  • Technical
  • Relative Strength Index (RSI)
  • HERZ N/A
  • SCLX 69.99
  • Support Level
  • HERZ N/A
  • SCLX $12.59
  • Resistance Level
  • HERZ N/A
  • SCLX $15.59
  • Average True Range (ATR)
  • HERZ 0.00
  • SCLX 2.11
  • MACD
  • HERZ 0.00
  • SCLX 0.23
  • Stochastic Oscillator
  • HERZ 0.00
  • SCLX 79.15

About HERZ Herzfeld Credit Income Fund Inc. Common Stock

Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: